http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101841042-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-872 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate | 2016-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101841042-B1 |
| titleOfInvention | Composition for improving or inhibiting side effect of cyclophosphamide |
| abstract | The present invention relates to a composition for improving or inhibiting adverse effects of cyclophosphamide, which is an anticancer agent, as an effective ingredient, or a pharmaceutically acceptable salt thereof, May be utilized as a pharmaceutical composition or a health food composition for improving or suppressing side effects. [Chemical Formula 1] In Formula 1, R 1 and R 2 may be the same or different and are selected from the group consisting of hydrogen, (C 1 -C 4) alkyl, (C 1 -C 4) alkoxy and halogen. |
| priorityDate | 2016-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 107.